Gregory B. Holmes

1.5k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Gregory B. Holmes is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Gregory B. Holmes has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 9 papers in Psychiatry and Mental health and 7 papers in Pharmacology. Recurrent topics in Gregory B. Holmes's work include Pharmacological Effects and Toxicity Studies (10 papers), Epilepsy research and treatment (9 papers) and Pharmaceutical studies and practices (6 papers). Gregory B. Holmes is often cited by papers focused on Pharmacological Effects and Toxicity Studies (10 papers), Epilepsy research and treatment (9 papers) and Pharmaceutical studies and practices (6 papers). Gregory B. Holmes collaborates with scholars based in United States, Australia and Lebanon. Gregory B. Holmes's co-authors include Pirow Bekker, Philip T. Leese, Steven W. Martin, Alex M. DePaoli, Donna Holloway, Robyn Murphy, Colin R. Dunstan, Nina M. Graves, Ilo E. Leppik and Rory P. Remmel and has published in prestigious journals such as Journal of Bone and Mineral Research, Epilepsia and Clinical Pharmacology & Therapeutics.

In The Last Decade

Gregory B. Holmes

18 papers receiving 1.1k citations

Hit Papers

A Single-Dose Placebo-Controlled Study of AMG 162, a Full... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory B. Holmes United States 13 582 441 334 283 269 18 1.2k
P. Clifton‐Bligh Australia 21 227 0.4× 201 0.5× 142 0.4× 31 0.1× 45 0.2× 54 1.1k
Michael Heathman United States 12 135 0.2× 170 0.4× 41 0.1× 41 0.1× 54 0.2× 24 604
E. Blind Germany 15 393 0.7× 433 1.0× 132 0.4× 26 0.1× 11 0.0× 48 1.1k
Oleg Tsuprykov Germany 22 169 0.3× 216 0.5× 70 0.2× 174 0.6× 19 0.1× 33 1.2k
Mary Anne Fallon United States 12 1.2k 2.0× 261 0.6× 633 1.9× 51 0.2× 27 0.1× 15 2.0k
P. D. Bewsher United Kingdom 20 113 0.2× 158 0.4× 95 0.3× 69 0.2× 21 0.1× 51 1.1k
Leonid Katz United States 12 622 1.1× 773 1.8× 551 1.6× 18 0.1× 9 0.0× 18 1.7k
Robert Josse Canada 10 426 0.7× 730 1.7× 252 0.8× 34 0.1× 9 0.0× 17 2.2k
Kazuyuki Saito Japan 15 176 0.3× 151 0.3× 22 0.1× 40 0.1× 23 0.1× 62 862
Ali Ziada United States 19 128 0.2× 345 0.8× 13 0.0× 195 0.7× 22 0.1× 48 1.4k

Countries citing papers authored by Gregory B. Holmes

Since Specialization
Citations

This map shows the geographic impact of Gregory B. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory B. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory B. Holmes more than expected).

Fields of papers citing papers by Gregory B. Holmes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory B. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory B. Holmes. The network helps show where Gregory B. Holmes may publish in the future.

Co-authorship network of co-authors of Gregory B. Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory B. Holmes. A scholar is included among the top collaborators of Gregory B. Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory B. Holmes. Gregory B. Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Holmes, Gregory B., Lawrence Galitz, Peter Hu, & William H. Lyness. (2005). Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment. British Journal of Clinical Pharmacology. 60(5). 469–476. 61 indexed citations
2.
Bekker, Pirow, Donna Holloway, Robyn Murphy, et al.. (2005). A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women. Journal of Bone and Mineral Research. 20(12). 2274–2282. 71 indexed citations
3.
Bekker, Pirow, Donna Holloway, Robyn Murphy, et al.. (2004). A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women. Journal of Bone and Mineral Research. 19(7). 1059–1066. 591 indexed citations breakdown →
4.
Abdel‐Rahman, Susan M., Franklin K. Johnson, Neil Manowitz, Gregory B. Holmes, & Gregory L. Kearns. (2002). Single-Dose Pharmacokinetics of Nizatidine (Axid®) in Children. The Journal of Clinical Pharmacology. 42(10). 1089–1096. 5 indexed citations
5.
Abdel‐Rahman, Susan M., Franklin K. Johnson, Neil Manowitz, Gregory B. Holmes, & Gregory L. Kearns. (2002). Single‐Dose Pharmacokinetics of Nizatidine (Axid®) in Children. The Journal of Clinical Pharmacology. 42(10). 1089–1096. 8 indexed citations
6.
Schwartz, Jules I., K. Vandormael, Rubana N. Kalyani, et al.. (2002). Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal‐salt diet. Clinical Pharmacology & Therapeutics. 72(1). 50–61. 125 indexed citations
7.
Schwartz, Jules I., Nancy Agrawal, Peggy H. Wong, et al.. (2001). Lack of Pharmacokinetic Interaction between Rofecoxib and Methotrexate in Rheumatoid Arthritis Patients. The Journal of Clinical Pharmacology. 41(10). 1120–1130. 26 indexed citations
8.
Mikati, Mohamad A., et al.. (1998). Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.. PubMed. 42 Suppl 1. 57–62. 30 indexed citations
9.
Holmes, Gregory B., et al.. (1992). Bioequivalence of verapamil hydrochloride extended-release pellet-filled capsules when opened and sprinkled on food and when swallowed intact.. PubMed. 11(6). 539–42. 8 indexed citations
10.
Wagner, Mary, et al.. (1991). Discontinuation of Phenytoin and Carbamazepine in Patients Receiving Felbamate. Epilepsia. 32(3). 398–406. 61 indexed citations
11.
Holmes, Gregory B., et al.. (1989). Pharmacokinetics of gabapentin in patients treated with phenytoin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(3). 196. 20 indexed citations
12.
Graves, Nina M., et al.. (1989). Effect of Felbamate on Phenytoin and Carbamazepine Serum Concentrations. Epilepsia. 30(2). 225–229. 68 indexed citations
13.
Graves, Nina M., et al.. (1989). Pharmacokinetics of Felbamate, a Novel Antiepileptic Drug: Application of Mixed‐Effect Modeling to Clinical Trials. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(6). 372–376. 22 indexed citations
14.
Holmes, Gregory B., et al.. (1989). Absorption of Valproic Acid Suppositories in Human Volunteers. Archives of Neurology. 46(8). 906–909. 11 indexed citations
15.
Graves, Nina M., et al.. (1989). Relative Bioavailability of Rectally Administered Phenobarbital Sodium Parenteral Solution. DICP. 23(7-8). 565–568. 12 indexed citations
16.
Graves, Nina M., et al.. (1988). Felbamate Increases Phenytoin but Decreases Carbamazepine Concentrations. Epilepsia. 29(4). 488–491. 58 indexed citations
17.
Graves, Nicholas, Gregory B. Holmes, & Ilo E. Leppik. (1988). Compliant populations: variability in serum concentrations.. PubMed. 1. 91–9. 12 indexed citations
18.
Graves, Nina M., et al.. (1987). Quantitative Determination of Phenytoin and Phenobarbital in Capillary Blood by Ames Seralyzer. Epilepsia. 28(6). 713–716. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026